Service de Rhumatologie, Département de Médecine, Faculté de Médecine et des Sciences de la Santé, Université de Sherbrooke, Centre de Recherche Clinique Etienne-Lebel and Institut de Pharmacologie de Sherbrooke, Sherbrooke, Quebec J1H 5N4, Canada.
J Biol Chem. 2010 Dec 24;285(52):40838-51. doi: 10.1074/jbc.M110.142257. Epub 2010 Oct 19.
Although the mechanisms that regulate folding and maturation of newly synthesized G protein-coupled receptors are crucial for their function, they remain poorly characterized. By yeast two-hybrid screening, we have isolated ANKRD13C, a protein of unknown function, as an interacting partner for the DP receptor for prostaglandin D(2). In the present study we report the characterization of this novel protein as a regulator of DP biogenesis and trafficking in the biosynthetic pathway. Co-localization by confocal microscopy with an endoplasmic reticulum (ER) marker, subcellular fractionation experiments, and demonstration of the interaction between ANKRD13C and the cytoplasmic C terminus of DP suggest that ANKRD13C is a protein associated with the cytosolic side of ER membranes. Co-expression of ANKRD13C with DP initially increased receptor protein levels, whereas siRNA-mediated knockdown of endogenous ANKRD13C decreased them. Pulse-chase experiments indicated that ANKRD13C can promote the biogenesis of DP by inhibiting the degradation of newly synthesized receptors. However, a prolonged interaction between ANKRD13C and DP resulted in ER retention of misfolded/unassembled forms of the receptor and to their proteasome-mediated degradation. ANKRD13C also regulated the expression of other GPCRs tested (CRTH2, thromboxane A(2) (TPα), and β2-adrenergic receptor), whereas it did not affect the expression of green fluorescent protein, GRK2 (G protein-coupled receptor kinase 2), and VSVG (vesicular stomatitis virus glycoprotein), showing specificity toward G protein-coupled receptors. Altogether, these results suggest that ANKRD13C acts as a molecular chaperone for G protein-coupled receptors, regulating their biogenesis and exit from the ER.
虽然调节新合成的 G 蛋白偶联受体折叠和成熟的机制对于其功能至关重要,但它们的特征仍然知之甚少。通过酵母双杂交筛选,我们分离到一种未知功能的蛋白 ANKRD13C,它是前列腺素 D2 的 DP 受体的相互作用伙伴。在本研究中,我们报道了这种新型蛋白作为 DP 生物发生和生物合成途径中转运的调节剂的特征。通过与内质网 (ER) 标志物的共聚焦显微镜共定位、亚细胞分级实验以及 ANKRD13C 与 DP 的细胞质 C 末端之间相互作用的证明,表明 ANKRD13C 是一种与 ER 膜胞质侧相关的蛋白。ANKRD13C 与 DP 的共表达最初增加了受体蛋白水平,而内源性 ANKRD13C 的 siRNA 介导的敲低则降低了它们。脉冲追踪实验表明,ANKRD13C 可以通过抑制新合成受体的降解来促进 DP 的生物发生。然而,ANKRD13C 与 DP 的长时间相互作用导致受体错误折叠/未组装形式的内质网保留和它们的蛋白酶体介导的降解。ANKRD13C 还调节了其他测试的 GPCR(CRTH2、血栓烷 A2 (TPα) 和β2-肾上腺素能受体)的表达,而不影响绿色荧光蛋白、GRK2(G 蛋白偶联受体激酶 2)和 VSVG(水疱性口炎病毒糖蛋白)的表达,显示出对 G 蛋白偶联受体的特异性。总之,这些结果表明 ANKRD13C 作为 G 蛋白偶联受体的分子伴侣,调节它们的生物发生和从 ER 中的逸出。